{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:29:07Z","timestamp":1790659747519,"version":"4.1.0"},"reference-count":147,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T00:00:00Z","timestamp":1563494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2019,7,19]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    The mammalian nervous system is invaded by a number of intracellular bacterial pathogens which can establish and progress infection in susceptible individuals. Subsequent clinical manifestation is apparent with the impairment of the functional units of the nervous system, i.e., the neurons and the supporting glial cells that produce myelin sheaths around axons and provide trophic support to axons and neurons. Most of these neurotrophic bacteria display unique features, have coevolved with the functional sophistication of the nervous system cells, and have adapted remarkably to manipulate neural cell functions for their own advantage. Understanding how these bacterial pathogens establish intracellular adaptation by hijacking endogenous pathways in the nervous system, initiating myelin damage and axonal degeneration, and interfering with myelin maintenance provides new knowledge not only for developing strategies to combat neurodegenerative conditions induced by these pathogens but also for gaining novel insights into cellular and molecular pathways that regulate nervous system functions. Since the pathways hijacked by bacterial pathogens may also be associated with other neurodegenerative diseases, it is anticipated that detailing the mechanisms of bacterial manipulation of neural systems may shed light on common mechanisms, particularly of early disease events. This chapter details a classic example of neurodegeneration, that caused by\n                    <jats:italic>Mycobacterium leprae<\/jats:italic>\n                    , which primarily infects glial cells of the peripheral nervous system (Schwann cells), and how it targets and adapts intracellularly by reprogramming Schwann cells to stem cells\/progenitor cells. We also discuss implications of this host cell reprogramming by leprosy bacilli as a model in a wider context.\n                  <\/jats:p>","DOI":"10.1128\/microbiolspec.bai-0020-2019","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T08:45:15Z","timestamp":1563525915000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":32,"title":["Cell Biology of Intracellular Adaptation of\n                    <i>Mycobacterium leprae<\/i>\n                    in the Peripheral Nervous System"],"prefix":"10.1128","volume":"7","author":[{"given":"Samuel","family":"Hess","sequence":"first","affiliation":[{"name":"Medical Research Council (MRC) Centre for Regenerative Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anura","family":"Rambukkana","sequence":"additional","affiliation":[{"name":"Medical Research Council (MRC) Centre for Regenerative Medicine"},{"name":"Centre for Edinburgh Infectious Diseases, University of Edinburgh, Edinburgh, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Drevets DA Leenen PJM Greenfield RA. 2004. Invasion of the central nervous system by intracellular bacteria. Clin Microbiol Rev 17: 323\u2013347 http:\/\/dx.doi.org\/10.1128\/CMR.17.2.323-347.2004. [PubMed]","DOI":"10.1128\/CMR.17.2.323-347.2004"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","unstructured":"Deigendesch N Stenzel W. 2018. Acute and chronic bacterial infections and sarcoidosis p 217\u2013226. In Handbook of Clinical Neurology . Elsevier New York NY. [PubMed]","DOI":"10.1016\/B978-0-12-802395-2.00016-X"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","unstructured":"Suthar R Sankhyan N. 2018. Bacterial infections of the central nervous system. Indian J Pediatr 86: 60\u201369. [PubMed]","DOI":"10.1007\/s12098-017-2477-z"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","unstructured":"Jessen KR Mirsky R. 2005. The origin and development of glial cells in peripheral nerves. Nat Rev Neurosci 6: 671\u2013682 http:\/\/dx.doi.org\/10.1038\/nrn1746. [PubMed]","DOI":"10.1038\/nrn1746"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","unstructured":"Jessen KR Mirsky R Lloyd AC. 2015. Schwann cells: development and role in nerve repair. Cold Spring Harb Perspect Biol 7: a020487 http:\/\/dx.doi.org\/10.1101\/cshperspect.a020487. [PubMed]","DOI":"10.1101\/cshperspect.a020487"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","unstructured":"Peltonen S Alanne M Peltonen J. 2013. Barriers of the peripheral nerve. Tissue Barriers 1: e24956 http:\/\/dx.doi.org\/10.4161\/tisb.24956. [PubMed]","DOI":"10.4161\/tisb.24956"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","unstructured":"Reinhold AK Rittner HL. 2017. Barrier function in the peripheral and central nervous system\u2014a review. Pflugers Arch 469: 123\u2013134 http:\/\/dx.doi.org\/10.1007\/s00424-016-1920-8. [PubMed]","DOI":"10.1007\/s00424-016-1920-8"},{"key":"e_1_3_2_9_2","unstructured":"World Health Organization. 2017. Global leprosy update 2016: accelerating reduction of disease burden. Wkly Epidemiol Rec 92: 501\u2013519."},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","unstructured":"van Brakel WH Post E Saunderson PR Gopal PK. 2017. Leprosy p 391\u2013401. In Quah SR (ed) International Encyclopedia of Public Health 2nd ed. Academic Press New York NY.","DOI":"10.1016\/B978-0-12-803678-5.00251-4"},{"key":"e_1_3_2_11_2","unstructured":"Browne SG. 1985. The history of leprosy p 1\u201314. In Hastings RC (ed) Leprosy . Churchill Livingstone Edinburgh United Kingdom."},{"key":"e_1_3_2_12_2","unstructured":"Hansen GHA. 1874. Unders\u00f8gelser ang\u00e5ende spedalskhedens \u00e5rsager (investigations concerning the etiology of leprosy). Nor Mag Laegervidenskaben 4: 1\u201388."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","unstructured":"Suzuki K Akama T Kawashima A Yoshihara A Yotsu RR Ishii N. 2012. Current status of leprosy: epidemiology basic science and clinical perspectives. J Dermatol 39: 121\u2013129 http:\/\/dx.doi.org\/10.1111\/j.1346-8138.2011.01370.x. [PubMed]","DOI":"10.1111\/j.1346-8138.2011.01370.x"},{"key":"e_1_3_2_14_2","unstructured":"World Health Organization. 2017. Global Leprosy Strategy 2016-2020 . World Health Organization Geneva Switzerland."},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","unstructured":"Cruz RCDS B\u00fchrer-S\u00e9kula S Penna MLF Penna GO Talhari S. 2017. Leprosy: current situation clinical and laboratory aspects treatment history and perspective of the uniform multidrug therapy for all patients. An Bras Dermatol 92: 761\u2013773 http:\/\/dx.doi.org\/10.1590\/abd1806-4841.20176724. [PubMed]","DOI":"10.1590\/abd1806-4841.20176724"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Cole ST et al. 2001. Massive gene decay in the leprosy bacillus. Nature 409: 1007\u20131011 http:\/\/dx.doi.org\/10.1038\/35059006.","DOI":"10.1038\/35059006"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","unstructured":"Singh P Cole ST. 2011. Mycobacterium leprae : genes pseudogenes and genetic diversity. Future Microbiol 6: 57\u201371 http:\/\/dx.doi.org\/10.2217\/fmb.10.153. [PubMed]","DOI":"10.2217\/fmb.10.153"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","unstructured":"Truman R. 2005. Leprosy in wild armadillos. Lepr Rev 76: 198\u2013208.","DOI":"10.47276\/lr.76.3.198"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","unstructured":"Balamayooran G Pena M Sharma R Truman RW. 2015. The armadillo as an animal model and reservoir host for Mycobacterium leprae . Clin Dermatol 33: 108\u2013115 http:\/\/dx.doi.org\/10.1016\/j.clindermatol.2014.07.001. [PubMed]","DOI":"10.1016\/j.clindermatol.2014.07.001"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","unstructured":"Avanzi C Del-Pozo J Benjak A Stevenson K Simpson VR Busso P McLuckie J Loiseau C Lawton C Schoening J Shaw DJ Piton J Vera-Cabrera L Velarde-Felix JS McDermott F Gordon SV Cole ST Meredith AL. 2016. Red squirrels in the British Isles are infected with leprosy bacilli. Science 354: 744\u2013747 http:\/\/dx.doi.org\/10.1126\/science.aah3783. [PubMed]","DOI":"10.1126\/science.aah3783"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","unstructured":"Scollard DM Truman RW Ebenezer GJ. 2015. Mechanisms of nerve injury in leprosy. Clin Dermatol 33: 46\u201354 http:\/\/dx.doi.org\/10.1016\/j.clindermatol.2014.07.008. [PubMed]","DOI":"10.1016\/j.clindermatol.2014.07.008"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","unstructured":"L\u00e1zaro FP Werneck RI Mackert CCO Cobat A Prevedello FC Pimentel RP Macedo GMM Eleut\u00e9rio MAM Vilar G Abel L Xavier MB Alca\u00efs A Mira MT. 2010. A major gene controls leprosy susceptibility in a hyperendemic isolated population from north of Brazil. J Infect Dis 201: 1598\u20131605 http:\/\/dx.doi.org\/10.1086\/652007. [PubMed]","DOI":"10.1086\/652007"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","unstructured":"Truman RW Singh P Sharma R Busso P Rougemont J Paniz-Mondolfi A Kapopoulou A Brisse S Scollard DM Gillis TP Cole ST. 2011. Probable zoonotic leprosy in the southern United States. N Engl J Med 364: 1626\u20131633 http:\/\/dx.doi.org\/10.1056\/NEJMoa1010536. [PubMed]","DOI":"10.1056\/NEJMoa1010536"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","unstructured":"Chopra R Ali S Srivastava AK Aggarwal S Kumar B Manvati S Kalaiarasan P Jena M Garg VK Bhattacharya SN Bamezai RNK. 2013. Mapping of PARK2 and PACRG overlapping regulatory region reveals LD structure and functional variants in association with leprosy in unrelated Indian population groups. PLoS Genet 9: e1003578 http:\/\/dx.doi.org\/10.1371\/journal.pgen.1003578. [PubMed]","DOI":"10.1371\/journal.pgen.1003578"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","unstructured":"Chopra R Kalaiarasan P Ali S Srivastava AK Aggarwal S Garg VK Bhattacharya SN Bamezai RNK. 2014. PARK2 and proinflammatory\/anti-inflammatory cytokine gene interactions contribute to the susceptibility to leprosy: a case-control study of North Indian population. BMJ Open 4: e004239 http:\/\/dx.doi.org\/10.1136\/bmjopen-2013-004239. [PubMed]","DOI":"10.1136\/bmjopen-2013-004239"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","unstructured":"Mira MT Alca\u00efs A Nguyen VT Moraes MO Di Flumeri C Vu HT Mai CP Nguyen TH Nguyen NB Pham XK Sarno EN Alter A Montpetit A Moraes ME Moraes JR Dor\u00e9 C Gallant CJ Lepage P Verner A Van De Vosse E Hudson TJ Abel L Schurr E. 2004. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427: 636\u2013640 http:\/\/dx.doi.org\/10.1038\/nature02326. [PubMed]","DOI":"10.1038\/nature02326"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","unstructured":"Domingo A Klein C. 2018. Genetics of Parkinson disease p 211\u2013227. In Handbook of Clinical Neurology . Elsevier New York NY. [PubMed]","DOI":"10.1016\/B978-0-444-63233-3.00014-2"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","unstructured":"Meng L Shen L Ji HF. 2019. Impact of infection on risk of Parkinson\u2019s disease: a quantitative assessment of case-control and cohort studies. J Neurovirol 25: 221\u2013228 http:\/\/dx.doi.org\/10.1007\/s13365-018-0707-4. [PubMed]","DOI":"10.1007\/s13365-018-0707-4"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","unstructured":"De Chiara G Marcocci ME Sgarbanti R Civitelli L Ripoli C Piacentini R Garaci E Grassi C Palamara AT. 2012. Infectious agents and neurodegeneration. Mol Neurobiol 46: 614\u2013638 http:\/\/dx.doi.org\/10.1007\/s12035-012-8320-7. [PubMed]","DOI":"10.1007\/s12035-012-8320-7"},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","unstructured":"Masaki T Rambukkana A. 2014. Neurodegeneration in leprosy: insights from model systems and patients p 217\u2013232. In Bentivoglio M Cavalheiro EA Kristensson K Patel NB (ed) Neglected Tropical Diseases and Conditions of the Nervous System . Springer New York NY. http:\/\/dx.doi.org\/10.1007\/978-1-4614-8100-3_12","DOI":"10.1007\/978-1-4614-8100-3_12"},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","unstructured":"Scollard DM Adams LB Gillis TP Krahenbuhl JL Truman RW Williams DL. 2006. The continuing challenges of leprosy. Clin Microbiol Rev 19: 338\u2013381 http:\/\/dx.doi.org\/10.1128\/CMR.19.2.338-381.2006. [PubMed]","DOI":"10.1128\/CMR.19.2.338-381.2006"},{"key":"e_1_3_2_32_2","unstructured":"Truman RW Krahenbuhl JL. 2001. Viable M. leprae as a research reagent. Int J Lepr Other Mycobact Dis 69: 1\u201312."},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","unstructured":"Colston MJ Hilson GRF. 1976. Growth of Mycobacterium leprae and M. marinum in congenitally athymic (nude) mice. Nature 262: 399\u2013401 http:\/\/dx.doi.org\/10.1038\/262399a0. [PubMed]","DOI":"10.1038\/262399a0"},{"key":"e_1_3_2_34_2","doi-asserted-by":"crossref","unstructured":"Truman RW Ebenezer GJ Pena MT Sharma R Balamayooran G Gillingwater TH Scollard DM McArthur JC Rambukkana A. 2014. The armadillo as a model for peripheral neuropathy in leprosy. ILAR J 54: 304\u2013314 http:\/\/dx.doi.org\/10.1093\/ilar\/ilt050. [PubMed]","DOI":"10.1093\/ilar\/ilt050"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","unstructured":"Sharma R Lahiri R Scollard DM Pena M Williams DL Adams LB Figarola J Truman RW. 2013. The armadillo: a model for the neuropathy of leprosy and potentially other neurodegenerative diseases. Dis Model Mech 6: 19\u201324 http:\/\/dx.doi.org\/10.1242\/dmm.010215. [PubMed]","DOI":"10.1242\/dmm.010215"},{"key":"e_1_3_2_36_2","unstructured":"Job CK. 1989. Nerve damage in leprosy. Int J Lepr Other Mycobact Dis 57: 532\u2013539."},{"key":"e_1_3_2_37_2","unstructured":"Jennekens FG van Brakel WH. 1998. Neuropathy in leprosy p 319\u2013339. In Latov N Wokke JHJ Kelly JJ Jr (ed) Immunological and Infectious Diseases of the Peripheral Nerves . Cambridge University Press Cambridge United Kingdom."},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","unstructured":"Rodrigues LC Lockwood DN. 2011. Leprosy now: epidemiology progress challenges and research gaps. Lancet Infect Dis 11: 464\u2013470 http:\/\/dx.doi.org\/10.1016\/S1473-3099(11)70006-8.","DOI":"10.1016\/S1473-3099(11)70006-8"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","unstructured":"Chen L Deng H Cui H Fang J Zuo Z Deng J Li Y Wang X Zhao L. 2017. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9: 7204\u20137218.","DOI":"10.18632\/oncotarget.23208"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","unstructured":"Ransohoff RM. 2016. How neuroinflammation contributes to neurodegeneration. Science 353: 777\u2013783 http:\/\/dx.doi.org\/10.1126\/science.aag2590. [PubMed]","DOI":"10.1126\/science.aag2590"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","unstructured":"Stoner GL. 1979. Importance of the neural predilection of Mycobacterium leprae in leprosy. Lancet ii: 994\u2013996 http:\/\/dx.doi.org\/10.1016\/S0140-6736(79)92564-9.","DOI":"10.1016\/S0140-6736(79)92564-9"},{"key":"e_1_3_2_42_2","doi-asserted-by":"crossref","unstructured":"Miko TL Le Maitre C Kinfu Y. 1993. Damage and regeneration of peripheral nerves in advanced treated leprosy. Lancet 342: 521\u2013525 http:\/\/dx.doi.org\/10.1016\/0140-6736(93)91647-5.","DOI":"10.1016\/0140-6736(93)91647-5"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","unstructured":"Ooi WW Srinivasan J. 2004. Leprosy and the peripheral nervous system: basic and clinical aspects. Muscle Nerve 30: 393\u2013409 http:\/\/dx.doi.org\/10.1002\/mus.20113. [PubMed]","DOI":"10.1002\/mus.20113"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","unstructured":"Rambukkana A. 2001. Molecular basis for the peripheral nerve predilection of Mycobacterium leprae . Curr Opin Microbiol 4: 21\u201327 http:\/\/dx.doi.org\/10.1016\/S1369-5274(00)00159-4.","DOI":"10.1016\/S1369-5274(00)00159-4"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","unstructured":"Nave K-A Werner HB. 2014. Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol 30: 503\u2013533 http:\/\/dx.doi.org\/10.1146\/annurev-cellbio-100913-013101. [PubMed]","DOI":"10.1146\/annurev-cellbio-100913-013101"},{"key":"e_1_3_2_46_2","doi-asserted-by":"crossref","unstructured":"Pereira JA Lebrun-Julien F Suter U. 2012. Molecular mechanisms regulating myelination in the peripheral nervous system. Trends Neurosci 35: 123\u2013134 http:\/\/dx.doi.org\/10.1016\/j.tins.2011.11.006. [PubMed]","DOI":"10.1016\/j.tins.2011.11.006"},{"key":"e_1_3_2_47_2","doi-asserted-by":"crossref","unstructured":"Taveggia C Feltri ML Wrabetz L. 2010. Signals to promote myelin formation and repair. Nat Rev Neurol 6: 276\u2013287 http:\/\/dx.doi.org\/10.1038\/nrneurol.2010.37. [PubMed]","DOI":"10.1038\/nrneurol.2010.37"},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","unstructured":"Ahrendsen JT Macklin W. 2013. Signaling mechanisms regulating myelination in the central nervous system. Neurosci Bull 29: 199\u2013215 http:\/\/dx.doi.org\/10.1007\/s12264-013-1322-2. [PubMed]","DOI":"10.1007\/s12264-013-1322-2"},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","unstructured":"Mitew S Hay CM Peckham H Xiao J Koenning M Emery B. 2014. Mechanisms regulating the development of oligodendrocytes and central nervous system myelin. Neuroscience 276: 29\u201347 http:\/\/dx.doi.org\/10.1016\/j.neuroscience.2013.11.029. [PubMed]","DOI":"10.1016\/j.neuroscience.2013.11.029"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","unstructured":"Nave KA. 2010. Myelination and support of axonal integrity by glia. Nature 468: 244\u2013252 http:\/\/dx.doi.org\/10.1038\/nature09614. [PubMed]","DOI":"10.1038\/nature09614"},{"key":"e_1_3_2_51_2","doi-asserted-by":"crossref","unstructured":"Ng V Zanazzi G Timpl R Talts JF Salzer JL Brennan PJ Rambukkana A. 2000. Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae . Cell 103: 511\u2013524 http:\/\/dx.doi.org\/10.1016\/S0092-8674(00)00142-2.","DOI":"10.1016\/S0092-8674(00)00142-2"},{"key":"e_1_3_2_52_2","doi-asserted-by":"crossref","unstructured":"Rambukkana A Salzer JL Yurchenco PD Tuomanen EI. 1997. Neural targeting of Mycobacterium leprae mediated by the G domain of the laminin-\u03b12 chain. Cell 88: 811\u2013821 http:\/\/dx.doi.org\/10.1016\/S0092-8674(00)81927-3.","DOI":"10.1016\/S0092-8674(00)81927-3"},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","unstructured":"Rambukkana A Zanazzi G Tapinos N Salzer JL. 2002. Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells. Science 296: 927\u2013931 http:\/\/dx.doi.org\/10.1126\/science.1067631. [PubMed]","DOI":"10.1126\/science.1067631"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","unstructured":"Tapinos N Ohnishi M Rambukkana A. 2006. ErbB2 receptor tyrosine kinase signaling mediates early demyelination induced by leprosy bacilli. Nat Med 12: 961\u2013966. CORRIGENDUM Nat Med 12: 1100 http:\/\/dx.doi.org\/10.1038\/nm1433. [PubMed]","DOI":"10.1038\/nm1433"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","unstructured":"Einheber S Milner TA Giancotti F Salzer JL. 1993. Axonal regulation of Schwann cell integrin expression suggests a role for alpha 6 beta 4 in myelination. J Cell Biol 123: 1223\u20131236 http:\/\/dx.doi.org\/10.1083\/jcb.123.5.1223. [PubMed]","DOI":"10.1083\/jcb.123.5.1223"},{"key":"e_1_3_2_56_2","doi-asserted-by":"crossref","unstructured":"Cornbrooks CJ Carey DJ McDonald JA Timpl R Bunge RP. 1983. In vivo and in vitro observations on laminin production by Schwann cells. Proc Natl Acad Sci USA 80: 3850\u20133854 http:\/\/dx.doi.org\/10.1073\/pnas.80.12.3850. [PubMed]","DOI":"10.1073\/pnas.80.12.3850"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","unstructured":"Jaakkola S Peltonen J Riccardi V Chu ML Uitto J. 1989. Type 1 neurofibromatosis: selective expression of extracellular matrix genes by Schwann cells perineurial cells and fibroblasts in mixed cultures. J Clin Invest 84: 253\u2013261 http:\/\/dx.doi.org\/10.1172\/JCI114148. [PubMed]","DOI":"10.1172\/JCI114148"},{"key":"e_1_3_2_58_2","doi-asserted-by":"crossref","unstructured":"Sanes JR Engvall E Butkowski R Hunter DD. 1990. Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J Cell Biol 111: 1685\u20131699 http:\/\/dx.doi.org\/10.1083\/jcb.111.4.1685. [PubMed]","DOI":"10.1083\/jcb.111.4.1685"},{"key":"e_1_3_2_59_2","doi-asserted-by":"crossref","unstructured":"Burgeson RE Chiquet M Deutzmann R Ekblom P Engel J Kleinman H Martin GR Meneguzzi G Paulsson M Sanes J Timpl R Tryggvason K Yamada Y Yurchenco PD. 1994. A new nomenclature for the laminins. Matrix Biol 14: 209\u2013211 http:\/\/dx.doi.org\/10.1016\/0945-053X(94)90184-8.","DOI":"10.1016\/0945-053X(94)90184-8"},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","unstructured":"Engvall E Wewer UM. 1996. Domains of laminin. J Cell Biochem 61: 493\u2013501 http:\/\/dx.doi.org\/10.1002\/(SICI)1097-4644(19960616)61:4<493::AID-JCB2>3.0.CO;2-J.","DOI":"10.1002\/(SICI)1097-4644(19960616)61:4<493::AID-JCB2>3.0.CO;2-J"},{"key":"e_1_3_2_61_2","doi-asserted-by":"crossref","unstructured":"Timpl R Brown JC. 1994. The laminins. Matrix Biol 14: 275\u2013281 http:\/\/dx.doi.org\/10.1016\/0945-053X(94)90192-9.","DOI":"10.1016\/0945-053X(94)90192-9"},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","unstructured":"Leivo I Engvall E. 1988. Merosin a protein specific for basement membranes of Schwann cells striated muscle and trophoblast is expressed late in nerve and muscle development. Proc Natl Acad Sci USA 85: 1544\u20131548 http:\/\/dx.doi.org\/10.1073\/pnas.85.5.1544. [PubMed]","DOI":"10.1073\/pnas.85.5.1544"},{"key":"e_1_3_2_63_2","doi-asserted-by":"crossref","unstructured":"Yurchenco PD O\u2019Rear JJ. 1994. Basal lamina assembly. Curr Opin Cell Biol 6: 674\u2013681 http:\/\/dx.doi.org\/10.1016\/0955-0674(94)90093-0.","DOI":"10.1016\/0955-0674(94)90093-0"},{"key":"e_1_3_2_64_2","doi-asserted-by":"crossref","unstructured":"Aumailley M Smyth N. 1998. The role of laminins in basement membrane function. J Anat 193: 1\u201321 http:\/\/dx.doi.org\/10.1046\/j.1469-7580.1998.19310001.x. [PubMed]","DOI":"10.1046\/j.1469-7580.1998.19310001.x"},{"key":"e_1_3_2_65_2","unstructured":"Sasaki T Timpl R. 1999. Laminins p 434\u2013443. In Kreis T Vale R (ed) Guidebook to the Extracellular Matrix Anchor and Adhesion Proteins 3rd ed. Oxford University Press Oxford United Kingdom."},{"key":"e_1_3_2_66_2","doi-asserted-by":"crossref","unstructured":"Bunge MB Bunge RP. 1986. Linkage between Schwann cell extracellular matrix production and ensheathment function. Ann N Y Acad Sci 486 (1 Neurofibromat) : 241\u2013247 http:\/\/dx.doi.org\/10.1111\/j.1749-6632.1986.tb48077.x. [PubMed]","DOI":"10.1111\/j.1749-6632.1986.tb48077.x"},{"key":"e_1_3_2_67_2","doi-asserted-by":"crossref","unstructured":"Henry MD Campbell KP. 1999. Dystroglycan inside and out. Curr Opin Cell Biol 11: 602\u2013607 http:\/\/dx.doi.org\/10.1016\/S0955-0674(99)00024-1.","DOI":"10.1016\/S0955-0674(99)00024-1"},{"key":"e_1_3_2_68_2","doi-asserted-by":"crossref","unstructured":"Talts JF Andac Z G\u00f6hring W Brancaccio A Timpl R. 1999. Binding of the G domains of laminin \u03b11 and \u03b12 chains and perlecan to heparin sulfatides \u03b1-dystroglycan and several extracellular matrix proteins. EMBO J 18: 863\u2013870 http:\/\/dx.doi.org\/10.1093\/emboj\/18.4.863. [PubMed]","DOI":"10.1093\/emboj\/18.4.863"},{"key":"e_1_3_2_69_2","doi-asserted-by":"crossref","unstructured":"Hohenester E Tisi D Talts JF Timpl R. 1999. The crystal structure of a laminin G-like module reveals the molecular basis of \u03b1-dystroglycan binding to laminins perlecan and agrin. Mol Cell 4: 783\u2013792 http:\/\/dx.doi.org\/10.1016\/S1097-2765(00)80388-3.","DOI":"10.1016\/S1097-2765(00)80388-3"},{"key":"e_1_3_2_70_2","doi-asserted-by":"crossref","unstructured":"Tisi D Talts JF Timpl R Hohenester E. 2000. Structure of the C-terminal laminin G-like domain pair of the laminin \u03b12 chain harbouring binding sites for \u03b1-dystroglycan and heparin. EMBO J 19: 1432\u20131440 http:\/\/dx.doi.org\/10.1093\/emboj\/19.7.1432. [PubMed]","DOI":"10.1093\/emboj\/19.7.1432"},{"key":"e_1_3_2_71_2","doi-asserted-by":"crossref","unstructured":"Rambukkana A. 2000. How does Mycobacterium leprae target the peripheral nervous system? Trends Microbiol 8: 23\u201328 http:\/\/dx.doi.org\/10.1016\/S0966-842X(99)01647-9.","DOI":"10.1016\/S0966-842X(99)01647-9"},{"key":"e_1_3_2_72_2","doi-asserted-by":"crossref","unstructured":"Marques MAM Ant\u00f4nio VL Sarno EN Brennan PJ Pessolani MCV. 2001. Binding of \u03b12-laminins by pathogenic and non-pathogenic mycobacteria and adherence to Schwann cells. J Med Microbiol 50: 23\u201328 http:\/\/dx.doi.org\/10.1099\/0022-2615-50-1-23. [PubMed]","DOI":"10.1099\/0022-2615-50-1-23"},{"key":"e_1_3_2_73_2","doi-asserted-by":"crossref","unstructured":"Anderson RJ. 1932. The chemistry of the lipoids of tubercle bacilli. Physiol Rev 12: 166\u2013189 http:\/\/dx.doi.org\/10.1152\/physrev.1932.12.2.166.","DOI":"10.1152\/physrev.1932.12.2.166"},{"key":"e_1_3_2_74_2","doi-asserted-by":"crossref","unstructured":"Hunter SW Brennan PJ. 1981. A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity. J Bacteriol 147: 728\u2013735.","DOI":"10.1128\/jb.147.3.728-735.1981"},{"key":"e_1_3_2_75_2","doi-asserted-by":"crossref","unstructured":"Hunter SW Fujiwara T Brennan PJ. 1982. Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae . J Biol Chem 257: 15072\u201315078.","DOI":"10.1016\/S0021-9258(18)33395-7"},{"key":"e_1_3_2_76_2","doi-asserted-by":"crossref","unstructured":"Brennan PJ. 1989. Structure of mycobacteria: recent developments in defining cell wall carbohydrates and proteins. Rev Infect Dis 11 (Suppl 2) : S420\u2013S430 http:\/\/dx.doi.org\/10.1093\/clinids\/11.Supplement_2.S420.","DOI":"10.1093\/clinids\/11.Supplement_2.S420"},{"key":"e_1_3_2_77_2","doi-asserted-by":"crossref","unstructured":"Rastogi N Frehel C David HL. 1986. Triple-layered structure of mycobacterial cell wall: evidence for the existence of a polysaccharide-rich outer layer in 18 mycobacterial species. Curr Microbiol 13: 237\u2013242 http:\/\/dx.doi.org\/10.1007\/BF01568645.","DOI":"10.1007\/BF01568645"},{"key":"e_1_3_2_78_2","doi-asserted-by":"crossref","unstructured":"Neill MA Klebanoff SJ. 1988. The effect of phenolic glycolipid-1 from Mycobacterium leprae on the antimicrobial activity of human macrophages. J Exp Med 167: 30\u201342 http:\/\/dx.doi.org\/10.1084\/jem.167.1.30. [PubMed]","DOI":"10.1084\/jem.167.1.30"},{"key":"e_1_3_2_79_2","doi-asserted-by":"crossref","unstructured":"Young DB Buchanan TM. 1983. A serological test for leprosy with a glycolipid specific for Mycobacterium leprae . Science 221: 1057\u20131059 http:\/\/dx.doi.org\/10.1126\/science.6348948. [PubMed]","DOI":"10.1126\/science.6348948"},{"key":"e_1_3_2_80_2","doi-asserted-by":"crossref","unstructured":"Schlesinger LS Horwitz MA. 1991. Phenolic glycolipid-1 of Mycobacterium leprae binds complement component C3 in serum and mediates phagocytosis by human monocytes. J Exp Med 174: 1031\u20131038 http:\/\/dx.doi.org\/10.1084\/jem.174.5.1031. [PubMed]","DOI":"10.1084\/jem.174.5.1031"},{"key":"e_1_3_2_81_2","doi-asserted-by":"crossref","unstructured":"Rambukkana A. 2004. Mycobacterium leprae -induced demyelination: a model for early nerve degeneration. Curr Opin Immunol 16: 511\u2013518 http:\/\/dx.doi.org\/10.1016\/j.coi.2004.05.021. [PubMed]","DOI":"10.1016\/j.coi.2004.05.021"},{"key":"e_1_3_2_82_2","doi-asserted-by":"crossref","unstructured":"Ehrig K Leivo I Argraves WS Ruoslahti E Engvall E. 1990. Merosin a tissue-specific basement membrane protein is a laminin-like protein. Proc Natl Acad Sci USA 87: 3264\u20133268 http:\/\/dx.doi.org\/10.1073\/pnas.87.9.3264. [PubMed]","DOI":"10.1073\/pnas.87.9.3264"},{"key":"e_1_3_2_83_2","doi-asserted-by":"crossref","unstructured":"Talts JF Timpl R. 1999. Mutation of a basic sequence in the laminin \u03b12LG3 module leads to a lack of proteolytic processing and has different effects on \u03b21 integrin-mediated cell adhesion and \u03b1-dystroglycan binding. FEBS Lett 458: 319\u2013323 http:\/\/dx.doi.org\/10.1016\/S0014-5793(99)01180-1.","DOI":"10.1016\/S0014-5793(99)01180-1"},{"key":"e_1_3_2_84_2","doi-asserted-by":"crossref","unstructured":"Talts JF Mann K Yamada Y Timpl R. 1998. Structural analysis and proteolytic processing of recombinant G domain of mouse laminin \u03b12 chain. FEBS Lett 426: 71\u201376 http:\/\/dx.doi.org\/10.1016\/S0014-5793(98)00312-3.","DOI":"10.1016\/S0014-5793(98)00312-3"},{"key":"e_1_3_2_85_2","doi-asserted-by":"crossref","unstructured":"Bernier SM Utani A Sugiyama S Doi T Polistina C Yamada Y. 1995. Cloning and expression of laminin \u03b12 chain (M-chain) in the mouse. Matrix Biol 14: 447\u2013455 http:\/\/dx.doi.org\/10.1016\/0945-053X(95)90002-0.","DOI":"10.1016\/0945-053X(95)90002-0"},{"key":"e_1_3_2_86_2","doi-asserted-by":"crossref","unstructured":"Sasaki M Kleinman HK Huber H Deutzmann R Yamada Y. 1988. Laminin a multidomain protein. The A chain has a unique globular domain and homology with the basement membrane proteoglycan and the laminin B chains. J Biol Chem 263: 16536\u201316544.","DOI":"10.1016\/S0021-9258(18)37424-6"},{"key":"e_1_3_2_87_2","doi-asserted-by":"crossref","unstructured":"Engvall E Earwicker D Haaparanta T Ruoslahti E Sanes JR. 1990. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul 1: 731\u2013740 http:\/\/dx.doi.org\/10.1091\/mbc.1.10.731. [PubMed]","DOI":"10.1091\/mbc.1.10.731"},{"key":"e_1_3_2_88_2","doi-asserted-by":"crossref","unstructured":"Patton BL Miner JH Chiu AY Sanes JR. 1997. Distribution and function of laminins in the neuromuscular system of developing adult and mutant mice. J Cell Biol 139: 1507\u20131521 http:\/\/dx.doi.org\/10.1083\/jcb.139.6.1507. [PubMed]","DOI":"10.1083\/jcb.139.6.1507"},{"key":"e_1_3_2_89_2","doi-asserted-by":"crossref","unstructured":"Campbell KP. 1995. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80: 675\u2013679 http:\/\/dx.doi.org\/10.1016\/0092-8674(95)90344-5.","DOI":"10.1016\/0092-8674(95)90344-5"},{"key":"e_1_3_2_90_2","doi-asserted-by":"crossref","unstructured":"Rambukkana A Yamada H Zanazzi G Mathus T Salzer JL Yurchenco PD Campbell KP Fischetti VA. 1998. Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae . Science 282: 2076\u20132079 http:\/\/dx.doi.org\/10.1126\/science.282.5396.2076. [PubMed]","DOI":"10.1126\/science.282.5396.2076"},{"key":"e_1_3_2_91_2","doi-asserted-by":"crossref","unstructured":"Ibraghimov-Beskrovnaya O Ervasti JM Leveille CJ Slaughter CA Sernett SW Campbell KP. 1992. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355: 696\u2013702 http:\/\/dx.doi.org\/10.1038\/355696a0. [PubMed]","DOI":"10.1038\/355696a0"},{"key":"e_1_3_2_92_2","doi-asserted-by":"crossref","unstructured":"Yamada H Denzer AJ Hori H Tanaka T Anderson LVB Fujita S Fukuta-Ohi H Shimizu T Ruegg MA Matsumura K. 1996. Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. J Biol Chem 271: 23418\u201323423 http:\/\/dx.doi.org\/10.1074\/jbc.271.38.23418. [PubMed]","DOI":"10.1074\/jbc.271.38.23418"},{"key":"e_1_3_2_93_2","doi-asserted-by":"crossref","unstructured":"Saito F Masaki T Kamakura K Anderson LVB Fujita S Fukuta-Ohi H Sunada Y Shimizu T Matsumura K. 1999. Characterization of the transmembrane molecular architecture of the dystroglycan complex in Schwann cells. J Biol Chem 274: 8240\u20138246 http:\/\/dx.doi.org\/10.1074\/jbc.274.12.8240. [PubMed]","DOI":"10.1074\/jbc.274.12.8240"},{"key":"e_1_3_2_94_2","doi-asserted-by":"crossref","unstructured":"Nave K-A Trapp BD. 2008. Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31: 535\u2013561 http:\/\/dx.doi.org\/10.1146\/annurev.neuro.30.051606.094309. [PubMed]","DOI":"10.1146\/annurev.neuro.30.051606.094309"},{"key":"e_1_3_2_95_2","doi-asserted-by":"crossref","unstructured":"Nave K-A Salzer JL. 2006. Axonal regulation of myelination by neuregulin 1. Curr Opin Neurobiol 16: 492\u2013500 http:\/\/dx.doi.org\/10.1016\/j.conb.2006.08.008. [PubMed]","DOI":"10.1016\/j.conb.2006.08.008"},{"key":"e_1_3_2_96_2","doi-asserted-by":"crossref","unstructured":"Lemke G. 2006. Neuregulin-1 and myelination. Sci STKE 2006: pe11. [PubMed]","DOI":"10.1126\/stke.3252006pe11"},{"key":"e_1_3_2_97_2","doi-asserted-by":"crossref","unstructured":"Riethmacher D Sonnenberg-Riethmacher E Brinkmann V Yamaai T Lewin GR Birchmeier C. 1997. Severe neuropathies in mice with targeted mutations in the ErbB3 receptor. Nature 389: 725\u2013730 http:\/\/dx.doi.org\/10.1038\/39593. [PubMed]","DOI":"10.1038\/39593"},{"key":"e_1_3_2_98_2","doi-asserted-by":"crossref","unstructured":"Garratt AN Britsch S Birchmeier C. 2000. Neuregulin a factor with many functions in the life of a Schwann cell. BioEssays 22: 987\u2013996 http:\/\/dx.doi.org\/10.1002\/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5.","DOI":"10.1002\/1521-1878(200011)22:11<987::AID-BIES5>3.0.CO;2-5"},{"key":"e_1_3_2_99_2","doi-asserted-by":"crossref","unstructured":"Guertin AD Zhang DP Mak KS Alberta JA Kim HA. 2005. Microanatomy of axon\/glial signaling during Wallerian degeneration. J Neurosci 25: 3478\u20133487 http:\/\/dx.doi.org\/10.1523\/JNEUROSCI.3766-04.2005. [PubMed]","DOI":"10.1523\/JNEUROSCI.3766-04.2005"},{"key":"e_1_3_2_100_2","doi-asserted-by":"crossref","unstructured":"Yarden Y Sliwkowski MX. 2001. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2: 127\u2013137 http:\/\/dx.doi.org\/10.1038\/35052073. [PubMed]","DOI":"10.1038\/35052073"},{"key":"e_1_3_2_101_2","doi-asserted-by":"crossref","unstructured":"Hynes NE Lane HA. 2005. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5: 341\u2013354 http:\/\/dx.doi.org\/10.1038\/nrc1609. [PubMed]","DOI":"10.1038\/nrc1609"},{"key":"e_1_3_2_102_2","doi-asserted-by":"crossref","unstructured":"Rambukkana A. 2010. Usage of signaling in neurodegeneration and regeneration of peripheral nerves by leprosy bacteria. Prog Neurobiol 91: 102\u2013107 http:\/\/dx.doi.org\/10.1016\/j.pneurobio.2009.12.002. [PubMed]","DOI":"10.1016\/j.pneurobio.2009.12.002"},{"key":"e_1_3_2_103_2","doi-asserted-by":"crossref","unstructured":"Waxman SG. 1998. Demyelinating diseases\u2014new pathological insights new therapeutic targets. N Engl J Med 338: 323\u2013325. [PubMed]","DOI":"10.1056\/NEJM199801293380610"},{"key":"e_1_3_2_104_2","doi-asserted-by":"crossref","unstructured":"Hess S Rambukkana A. 2015. Bacterial-induced cell reprogramming to stem cell-like cells: new premise in host-pathogen interactions. Curr Opin Microbiol 23: 179\u2013188 http:\/\/dx.doi.org\/10.1016\/j.mib.2014.11.021. [PubMed]","DOI":"10.1016\/j.mib.2014.11.021"},{"key":"e_1_3_2_105_2","doi-asserted-by":"crossref","unstructured":"Madigan CA Cambier CJ Kelly-Scumpia KM Scumpia PO Cheng TY Zailaa J Bloom BR Moody DB Smale ST Sagasti A Modlin RL Ramakrishnan L. 2017. A macrophage response to Mycobacterium leprae phenolic glycolipid initiates nerve damage in leprosy. Cell 170: 973\u2013985.E10 http:\/\/dx.doi.org\/10.1016\/j.cell.2017.07.030. [PubMed]","DOI":"10.1016\/j.cell.2017.07.030"},{"key":"e_1_3_2_106_2","doi-asserted-by":"crossref","unstructured":"Kim HA Mindos T Parkinson DB. 2013. Plastic fantastic: Schwann cells and repair of the peripheral nervous system. Stem Cells Transl Med 2: 553\u2013557 http:\/\/dx.doi.org\/10.5966\/sctm.2013-0011. [PubMed]","DOI":"10.5966\/sctm.2013-0011"},{"key":"e_1_3_2_107_2","doi-asserted-by":"crossref","unstructured":"Jessen KR Mirsky R. 2016. The repair Schwann cell and its function in regenerating nerves. J Physiol 594: 3521\u20133531 http:\/\/dx.doi.org\/10.1113\/JP270874. [PubMed]","DOI":"10.1113\/JP270874"},{"key":"e_1_3_2_108_2","doi-asserted-by":"crossref","unstructured":"Tapinos N Rambukkana A. 2005. Insights into regulation of human Schwann cell proliferation by Erk1\/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli. Proc Natl Acad Sci USA 102: 9188\u20139193 http:\/\/dx.doi.org\/10.1073\/pnas.0501196102. [PubMed]","DOI":"10.1073\/pnas.0501196102"},{"key":"e_1_3_2_109_2","doi-asserted-by":"crossref","unstructured":"Kim HA Pomeroy SL Whoriskey W Pawlitzky I Benowitz LI Sicinski P Stiles CD Roberts TM. 2000. A developmentally regulated switch directs regenerative growth of Schwann cells through cyclin D1. Neuron 26: 405\u2013416 http:\/\/dx.doi.org\/10.1016\/S0896-6273(00)81173-3.","DOI":"10.1016\/S0896-6273(00)81173-3"},{"key":"e_1_3_2_110_2","doi-asserted-by":"crossref","unstructured":"Stoll G Jander S Myers RR. 2002. Degeneration and regeneration of the peripheral nervous system: From Augustus Waller\u2019s observations to neuroinflammation. J Peripher Nerv Syst 7: 13\u201327. [PubMed]","DOI":"10.1046\/j.1529-8027.2002.02002.x"},{"key":"e_1_3_2_111_2","doi-asserted-by":"crossref","unstructured":"Masaki T Qu J Cholewa-Waclaw J Burr K Raaum R Rambukkana A. 2013. Reprogramming adult Schwann cells to stem cell-like cells by leprosy bacilli promotes dissemination of infection. Cell 152: 51\u201367 http:\/\/dx.doi.org\/10.1016\/j.cell.2012.12.014. [PubMed]","DOI":"10.1016\/j.cell.2012.12.014"},{"key":"e_1_3_2_112_2","doi-asserted-by":"crossref","unstructured":"Harrisingh MC Perez-Nadales E Parkinson DB Malcolm DS Mudge AW Lloyd AC. 2004. The Ras\/Raf\/ERK signalling pathway drives Schwann cell dedifferentiation. EMBO J 23: 3061\u20133071 http:\/\/dx.doi.org\/10.1038\/sj.emboj.7600309. [PubMed]","DOI":"10.1038\/sj.emboj.7600309"},{"key":"e_1_3_2_113_2","doi-asserted-by":"crossref","unstructured":"Pearson JM Rees RJ Weddell AG. 1970. Mycobacterium leprae in the striated muscle of patients with leprosy. Lepr Rev 41: 155\u2013166 http:\/\/dx.doi.org\/10.5935\/0305-7518.19700023. [PubMed]","DOI":"10.5935\/0305-7518.19700023"},{"key":"e_1_3_2_114_2","doi-asserted-by":"crossref","unstructured":"Werneck LC Teive HA Scola RH. 1999. Muscle involvement in leprosy. Study of the anterior tibial muscle in 40 patients. Arq Neuropsiquiatr 57 (3B) : 723\u2013734 http:\/\/dx.doi.org\/10.1590\/S0004-282X1999000500001. [PubMed]","DOI":"10.1590\/S0004-282X1999000500001"},{"key":"e_1_3_2_115_2","doi-asserted-by":"crossref","unstructured":"Masaki T McGlinchey A Tomlinson SR Qu J Rambukkana A. 2013. Reprogramming diminishes retention of Mycobacterium leprae in Schwann cells and elevates bacterial transfer property to fibroblasts. F1000 Res 2: 198 http:\/\/dx.doi.org\/10.12688\/f1000research.2-198.v1. [PubMed]","DOI":"10.12688\/f1000research.2-198.v1"},{"key":"e_1_3_2_116_2","doi-asserted-by":"crossref","unstructured":"Finzsch M Schreiner S Kichko T Reeh P Tamm ER B\u00f6sl MR Meijer D Wegner M. 2010. Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. J Cell Biol 189: 701\u2013712 http:\/\/dx.doi.org\/10.1083\/jcb.200912142. [PubMed]","DOI":"10.1083\/jcb.200912142"},{"key":"e_1_3_2_117_2","doi-asserted-by":"crossref","unstructured":"Bremer M Fr\u00f6b F Kichko T Reeh P Tamm ER Suter U Wegner M. 2011. Sox10 is required for Schwann-cell homeostasis and myelin maintenance in the adult peripheral nerve. Glia 59: 1022\u20131032 http:\/\/dx.doi.org\/10.1002\/glia.21173. [PubMed]","DOI":"10.1002\/glia.21173"},{"key":"e_1_3_2_118_2","doi-asserted-by":"crossref","unstructured":"Britsch S Goerich DE Riethmacher D Peirano RI Rossner M Nave KA Birchmeier C Wegner M. 2001. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev 15: 66\u201378 http:\/\/dx.doi.org\/10.1101\/gad.186601. [PubMed]","DOI":"10.1101\/gad.186601"},{"key":"e_1_3_2_119_2","doi-asserted-by":"crossref","unstructured":"Mirsky R Woodhoo A Parkinson DB Arthur-Farraj P Bhaskaran A Jessen KR. 2008. Novel signals controlling embryonic Schwann cell development myelination and dedifferentiation. J Peripher Nerv Syst 13: 122\u2013135. [PubMed]","DOI":"10.1111\/j.1529-8027.2008.00168.x"},{"key":"e_1_3_2_120_2","doi-asserted-by":"crossref","unstructured":"Fr\u00f6b F Bremer M Finzsch M Kichko T Reeh P Tamm ER Charnay P Wegner M. 2012. Establishment of myelinating Schwann cells and barrier integrity between central and peripheral nervous systems depend on Sox10. Glia 60: 806\u2013819 http:\/\/dx.doi.org\/10.1002\/glia.22310. [PubMed]","DOI":"10.1002\/glia.22310"},{"key":"e_1_3_2_121_2","doi-asserted-by":"crossref","unstructured":"Le N Nagarajan R Wang JYT Araki T Schmidt RE Milbrandt J. 2005. Analysis of congenital hypomyelinating Egr2Lo\/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Natl Acad Sci USA 102: 2596\u20132601 http:\/\/dx.doi.org\/10.1073\/pnas.0407836102. [PubMed]","DOI":"10.1073\/pnas.0407836102"},{"key":"e_1_3_2_122_2","doi-asserted-by":"crossref","unstructured":"Jessen KR Mirsky R. 2008. Negative regulation of myelination: relevance for development injury and demyelinating disease. Glia 56: 1552\u20131565 http:\/\/dx.doi.org\/10.1002\/glia.20761. [PubMed]","DOI":"10.1002\/glia.20761"},{"key":"e_1_3_2_123_2","doi-asserted-by":"crossref","unstructured":"Roberts SL Dun XP Doddrell RDS Mindos T Drake LK Onaitis MW Florio F Quattrini A Lloyd AC D\u2019Antonio M Parkinson DB. 2017. Sox2 expression in Schwann cells inhibits myelination in vivo and induces influx of macrophages to the nerve. Development 144: 3114\u20133125 http:\/\/dx.doi.org\/10.1242\/dev.150656. [PubMed]","DOI":"10.1242\/dev.150656"},{"key":"e_1_3_2_124_2","doi-asserted-by":"crossref","unstructured":"Chambers I Tomlinson SR. 2009. The transcriptional foundation of pluripotency. Development 136: 2311\u20132322 http:\/\/dx.doi.org\/10.1242\/dev.024398. [PubMed]","DOI":"10.1242\/dev.024398"},{"key":"e_1_3_2_125_2","doi-asserted-by":"crossref","unstructured":"Wang J Rao S Chu J Shen X Levasseur DN Theunissen TW Orkin SH. 2006. A protein interaction network for pluripotency of embryonic stem cells. Nature 444: 364\u2013368 http:\/\/dx.doi.org\/10.1038\/nature05284. [PubMed]","DOI":"10.1038\/nature05284"},{"key":"e_1_3_2_126_2","doi-asserted-by":"crossref","unstructured":"Miyagi S Masui S Niwa H Saito T Shimazaki T Okano H Nishimoto M Muramatsu M Iwama A Okuda A. 2008. Consequence of the loss of Sox2 in the developing brain of the mouse. FEBS Lett 582: 2811\u20132815 http:\/\/dx.doi.org\/10.1016\/j.febslet.2008.07.011. [PubMed]","DOI":"10.1016\/j.febslet.2008.07.011"},{"key":"e_1_3_2_127_2","doi-asserted-by":"crossref","unstructured":"Favaro R Valotta M Ferri ALM Latorre E Mariani J Giachino C Lancini C Tosetti V Ottolenghi S Taylor V Nicolis SK. 2009. Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nat Neurosci 12: 1248\u20131256 http:\/\/dx.doi.org\/10.1038\/nn.2397. [PubMed]","DOI":"10.1038\/nn.2397"},{"key":"e_1_3_2_128_2","doi-asserted-by":"crossref","unstructured":"Komitova M Eriksson PS. 2004. Sox-2 is expressed by neural progenitors and astroglia in the adult rat brain. Neurosci Lett 369: 24\u201327 http:\/\/dx.doi.org\/10.1016\/j.neulet.2004.07.035. [PubMed]","DOI":"10.1016\/j.neulet.2004.07.035"},{"key":"e_1_3_2_129_2","doi-asserted-by":"crossref","unstructured":"Cavallaro M Mariani J Lancini C Latorre E Caccia R Gullo F Valotta M DeBiasi S Spinardi L Ronchi A Wanke E Brunelli S Favaro R Ottolenghi S Nicolis SK. 2008. Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants. Development 135: 541\u2013557 http:\/\/dx.doi.org\/10.1242\/dev.010801. [PubMed]","DOI":"10.1242\/dev.010801"},{"key":"e_1_3_2_130_2","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-L\u00f3pez S Wiskow O Favaro R Nicolis SK Price DJ Pollard SM Smith A. 2011. Sox2 and Pax6 maintain the proliferative and developmental potential of gliogenic neural stem cells in vitro. Glia 59: 1588\u20131599 http:\/\/dx.doi.org\/10.1002\/glia.21201. [PubMed]","DOI":"10.1002\/glia.21201"},{"key":"e_1_3_2_131_2","doi-asserted-by":"crossref","unstructured":"Cimadamore F Fishwick K Giusto E Gnedeva K Cattarossi G Miller A Pluchino S Brill LM Bronner-Fraser M Terskikh AV. 2011. Human ESC-derived neural crest model reveals a key role for SOX2 in sensory neurogenesis. Cell Stem Cell 8: 538\u2013551 http:\/\/dx.doi.org\/10.1016\/j.stem.2011.03.011. [PubMed]","DOI":"10.1016\/j.stem.2011.03.011"},{"key":"e_1_3_2_132_2","doi-asserted-by":"crossref","unstructured":"Taranova OV Magness ST Fagan BM Wu Y Surzenko N Hutton SR Pevny LH. 2006. SOX2 is a dose-dependent regulator of retinal neural progenitor competence. Genes Dev 20: 1187\u20131202 http:\/\/dx.doi.org\/10.1101\/gad.1407906. [PubMed]","DOI":"10.1101\/gad.1407906"},{"key":"e_1_3_2_133_2","doi-asserted-by":"crossref","unstructured":"Surzenko N Crowl T Bachleda A Langer L Pevny L. 2013. SOX2 maintains the quiescent progenitor cell state of postnatal retinal Muller glia. Development 140: 1445\u20131456 http:\/\/dx.doi.org\/10.1242\/dev.071878. [PubMed]","DOI":"10.1242\/dev.071878"},{"key":"e_1_3_2_134_2","doi-asserted-by":"crossref","unstructured":"Jaenisch R Young R. 2008. Stem cells the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132: 567\u2013582 http:\/\/dx.doi.org\/10.1016\/j.cell.2008.01.015. [PubMed]","DOI":"10.1016\/j.cell.2008.01.015"},{"key":"e_1_3_2_135_2","doi-asserted-by":"crossref","unstructured":"Kim J Chu J Shen X Wang J Orkin SH. 2008. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 132: 1049\u20131061 http:\/\/dx.doi.org\/10.1016\/j.cell.2008.02.039. [PubMed]","DOI":"10.1016\/j.cell.2008.02.039"},{"key":"e_1_3_2_136_2","doi-asserted-by":"crossref","unstructured":"Young RA. 2011. Control of the embryonic stem cell state. Cell 144: 940\u2013954 http:\/\/dx.doi.org\/10.1016\/j.cell.2011.01.032. [PubMed]","DOI":"10.1016\/j.cell.2011.01.032"},{"key":"e_1_3_2_137_2","doi-asserted-by":"crossref","unstructured":"De Los Angeles A Ferrari F Xi R Fujiwara Y Benvenisty N Deng H Hochedlinger K Jaenisch R Lee S Leitch HG Lensch MW Lujan E Pei D Rossant J Wernig M Park PJ Daley GQ. 2015. Hallmarks of pluripotency. Nature 525: 469\u2013478. CORRIGENDUM Nature 531: 400 http:\/\/dx.doi.org\/10.1038\/nature15515. [PubMed]","DOI":"10.1038\/nature15515"},{"key":"e_1_3_2_138_2","doi-asserted-by":"crossref","unstructured":"Lodato MA Ng CW Wamstad JA Cheng AW Thai KK Fraenkel E Jaenisch R Boyer LA. 2013. SOX2 co-occupies distal enhancer elements with distinct POU factors in ESCs and NPCs to specify cell state. PLoS Genet 9: e1003288 http:\/\/dx.doi.org\/10.1371\/journal.pgen.1003288. [PubMed]","DOI":"10.1371\/journal.pgen.1003288"},{"key":"e_1_3_2_139_2","doi-asserted-by":"crossref","unstructured":"Avilion AA Nicolis SK Pevny LH Perez L Vivian N Lovell-Badge R. 2003. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 17: 126\u2013140 http:\/\/dx.doi.org\/10.1101\/gad.224503. [PubMed]","DOI":"10.1101\/gad.224503"},{"key":"e_1_3_2_140_2","doi-asserted-by":"crossref","unstructured":"Arnold K Sarkar A Yram MA Polo JM Bronson R Sengupta S Seandel M Geijsen N Hochedlinger K. 2011. Sox2 + adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell 9: 317\u2013329 http:\/\/dx.doi.org\/10.1016\/j.stem.2011.09.001. [PubMed]","DOI":"10.1016\/j.stem.2011.09.001"},{"key":"e_1_3_2_141_2","doi-asserted-by":"crossref","unstructured":"Ellis P Fagan BM Magness ST Hutton S Taranova O Hayashi S McMahon A Rao M Pevny L. 2004. SOX2 a persistent marker for multipotential neural stem cells derived from embryonic stem cells the embryo or the adult. Dev Neurosci 26: 148\u2013165 http:\/\/dx.doi.org\/10.1159\/000082134.","DOI":"10.1159\/000082134"},{"key":"e_1_3_2_142_2","doi-asserted-by":"crossref","unstructured":"Lim J Thiery JP. 2012. Epithelial-mesenchymal transitions: insights from development. Development 139: 3471\u20133486 http:\/\/dx.doi.org\/10.1242\/dev.071209. [PubMed]","DOI":"10.1242\/dev.071209"},{"key":"e_1_3_2_143_2","doi-asserted-by":"crossref","unstructured":"Masaki T McGlinchey A Cholewa-Waclaw J Qu J Tomlinson SR Rambukkana A. 2014. Innate immune response precedes Mycobacterium leprae -induced reprogramming of adult Schwann cells. Cell Reprogram 16: 9\u201317 http:\/\/dx.doi.org\/10.1089\/cell.2013.0064. [PubMed]","DOI":"10.1089\/cell.2013.0064"},{"key":"e_1_3_2_144_2","doi-asserted-by":"crossref","unstructured":"Modlin RL Rea TH. 1988. Immunopathology of leprosy granulomas. Springer Semin Immunopathol 10: 359\u2013374 http:\/\/dx.doi.org\/10.1007\/BF02053846. [PubMed]","DOI":"10.1007\/BF02053846"},{"key":"e_1_3_2_145_2","doi-asserted-by":"crossref","unstructured":"Chan J Flynn J. 2004. The immunological aspects of latency in tuberculosis. Clin Immunol 110: 2\u201312 http:\/\/dx.doi.org\/10.1016\/S1521-6616(03)00210-9.","DOI":"10.1016\/S1521-6616(03)00210-9"},{"key":"e_1_3_2_146_2","doi-asserted-by":"crossref","unstructured":"Bold TD Ernst JD. 2009. Who benefits from granulomas mycobacteria or host? Cell 136: 17\u201319 http:\/\/dx.doi.org\/10.1016\/j.cell.2008.12.032. [PubMed]","DOI":"10.1016\/j.cell.2008.12.032"},{"key":"e_1_3_2_147_2","doi-asserted-by":"crossref","unstructured":"Qiu B Frait KA Reich F Komuniecki E Chensue SW. 2001. Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am J Pathol 158: 1503\u20131515 http:\/\/dx.doi.org\/10.1016\/S0002-9440(10)64101-6.","DOI":"10.1016\/S0002-9440(10)64101-6"},{"key":"e_1_3_2_148_2","doi-asserted-by":"crossref","unstructured":"Chiu B-C Freeman CM Stolberg VR Hu JS Komuniecki E Chensue SW. 2004. The innate pulmonary granuloma: characterization and demonstration of dendritic cell recruitment and function. Am J Pathol 164: 1021\u20131030 http:\/\/dx.doi.org\/10.1016\/S0002-9440(10)63189-6.","DOI":"10.1016\/S0002-9440(10)63189-6"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/microbiolspec.BAI-0020-2019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/microbiolspec.BAI-0020-2019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T03:23:47Z","timestamp":1646709827000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/microbiolspec.BAI-0020-2019"}},"subtitle":[],"editor":[{"given":"Pascale","family":"Cossart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Craig R.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Philippe","family":"Sansonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,7,19]]},"references-count":147,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7,19]]}},"alternative-id":["10.1128\/microbiolspec.BAI-0020-2019"],"URL":"https:\/\/doi.org\/10.1128\/microbiolspec.bai-0020-2019","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,19]]},"assertion":[{"value":"2018-09-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"7.4.13"}}